Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesEur. J. Cancer 2023 Nov 01;193(xx)113311, JSJ Lim, SGW Ow, ALA Wong, MXW Lee, GHJ Chan, JL Low, R Sundar, JRE Choo, WQ Chong, YLE Ang, BC Tai, SC Lee
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.